The latest issue of European Biotechnology covers the ins and outs of gene therapy pricing, sustainable finance and antimicrobial resistance.
For the 32nd time, the standard work of the biotechnology industry in Germany, Austria and Switzerland has been published. Once again, this year’s BioTechnology Yearbook provides a comprehensive overview of the various aspects of this sector of the economy
Novel biomarkers are the focus of the latest issue of European Biotechnology. Other stories cover malaria vaccinations, biomanufacturing and the bioeconomy.
Radiopharmaceuticals have made it to the title of the second issue of |transkript this year, next to topics such as haemophilia, synthetical bacterial genomes and biomanufacturing.
The 9th edition of the European Biotechnology Science & Industry Guide once more offers an interesting cross-section of the European biotech scene.
BIOCOMFighting metastases: The cover story in the newly published European Biotechnology presents the latest approaches in the fight against cancer.
For the fourth time now, the “Guide to German Medtech Companies” will be published this year.
BIOCOMMarijuana is the most widely trafficked illegal drug worldwide. But the list of European countries that see the clear medical benefits of the plant and want to legalise cannabis for medical purposes has grown long. Is this the beginning of a gold rush in the industry? The cover story of the recently published winter edition of European Biotechnology focuses on this issue.
What’s the latest in hemophilia therapeutics? Why could nanobots be the future of medicine? These are just two of the topics covered in the freshly printed issue of European Biotechnology.